SBIR Phase I: MAUI Imaging 2D Probe for COVID-19
- Funded by National Science Foundation (NSF)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$254,872Funder
National Science Foundation (NSF)Principal Investigator
David SpechtResearch Location
United States of AmericaLead Research Institution
MAUI IMAGING INCResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
Digital HealthInnovation
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is an new way of imaging the entire chest and lungs, a critical capability in assisting physicians treat COVID-19 patients. Identification of COVID-19 patients with lung conditions enables accurate triage to appropriate care levels. Current imaging modalities are limited: CT scans are limited by logistics of patient flow, re-sterilization after use, cost, and radiation risk; and conventional ultrasound cannot penetrate the full depth of lung tissue. The proposed project will develop a portable ultrasound system for bedside low-cost, non-invasive, highly accurate imaging of the lung, delivered via remote streaming and control, for the complex logistics of COVID-19 patient care.
This Small Business Innovation Research (SBIR) Phase I project will develop a portable ultrasound system for bedside non-invasive, highly accurate imaging of the lung parenchyma, mediastinum, and pleura. This project will develop core transducer components for integration into ultrasound probes, creating a 2-D imaging probe using 1-D transducer arrays. These 2-D arrays could ultimately be extended into a 3-D probe with full tomographic capabilities. The project will demonstrate the capability for lung imaging with sufficient quality to distinguish COVID-19 related issues without the need for accurate positioning, alignment, or registration.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
This Small Business Innovation Research (SBIR) Phase I project will develop a portable ultrasound system for bedside non-invasive, highly accurate imaging of the lung parenchyma, mediastinum, and pleura. This project will develop core transducer components for integration into ultrasound probes, creating a 2-D imaging probe using 1-D transducer arrays. These 2-D arrays could ultimately be extended into a 3-D probe with full tomographic capabilities. The project will demonstrate the capability for lung imaging with sufficient quality to distinguish COVID-19 related issues without the need for accurate positioning, alignment, or registration.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.